Viewing StudyNCT00473005



Ignite Creation Date: 2024-05-05 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00473005
Status: TERMINATED
Last Update Posted: 2012-05-28
First Post: 2007-05-11

Brief Title: Phase I Oral mTOR Inhibitor RAD001 in Combo w Capecitabine for Metastatic Breast
Sponsor: Stanford University
Organization: Stanford University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-08
Start Date Type: None
Primary Completion Date: 2011-12
Primary Completion Date Type: ACTUAL
Completion Date: 2011-12
Completion Date Type: ACTUAL
First Submit Date: 2007-05-11
First Submit QC Date: May 11 2007
Study First Post Date: 2007-05-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-05-24
Last Update Post Date: 2012-05-28
Last Update Post Date Type: ESTIMATED